Board of Directors and President

Leif Carlsson (1957), Stockholm, Sweden
Elected 2008
Primary education: Degree in Economics and Business Administration
Primary experience: Head of Strategy and Finance SBC Sveriges BostadsrättsCentrum AB (publ.) 2008 -; Chief Executive Officer of WM-data Sweden 2000 - 2004; Chief Financial Officer of the WM-data Group 1985 - 2000
Other significant engagements: Advisory Board Meritmind AB
Shares in Karo Bio: none
Independent board member

Dana Fowlkes (1950), Chapel Hill, North Carolina, USA
Elected 2000
Primary education or title: B.A. Colgate University, M.D. and Ph.D. Cornell University
Primary experience: Chief Scientific Officer of Karo Bio 2000-2002, Founder of Novalon Pharmaceuticals Inc., Physician, Associate Professor of Pathology University of North Carolina at Chapel Hill, Pharmaceutical Research
Other significant engagements: General Partner, Hatteras BioCapital Fund LLC; Venture Partner, Hatteras Venture Partner III Fund; Director, Lost Horizon Resort Co
Shares in Karo Bio: 848 770
Independent board member

Laurent Leksell (1952), Dalarö, Sweden
Elected 2006
Primary education or title: Ph.D. Business Administration, Stockholm School of Economics.
Primary experience: President and CEO of Elekta AB
Other significant engagements: Ortivus AB, Stockholm City Mission (chairman), American Chamber of Commerce, Royal University College of Fine Arts
Shares in Karo Bio: 850 000
Independent board member

Leon E. Rosenberg (1933), Princeton, New Jersey, USA
Elected 2000; Chairman from 2007
Primary education: B.A. and M.D., University of Wisconsin
Title: Professor of Molecular Biology, Princeton University
Primary experience: participant in, leader of, and advocate for health and medical research in government, academia and industry; former Chief Scientific Officer, Bristol-Myers Squibb Company; former Chairman of Dept. of Human Genetics, and Dean, Yale University School of Medicine; Elected member, National Academy of Sciences, USA
Other significant engagements: Chair, Board of Directors, Hana Biosciences Company
Shares in Karo Bio: 1 754
Independent board member

Birgit Stattin Norinder (1948), London, United Kingdom
Elected 2007
Primary education or title: M.Sc.Pharm.
Primary experience: Long experience from leading positions within research and development in several international pharmaceutical companies
Other significant engagements: InDex Pharmaceuticals AB (chairman), Lauras AS (chairman), Antisoma plc, deCODE genetics Inc., Photocure ASA
Shares in Karo Bio: none
Independent board member

Per Olof Wallström (1949), Uppsala, Sweden
Elected 2005
Primary education or title: President Karo Bio, M.Sc. Pharm.
Primary experience: Long experience from international pharmaceutical industry and biotechnology including President of Melacure Therapeutics AB and Q-Med AB and President of Northern Central and Eastern Europe and other senior positions with Bristol-Myers Squibb
Other significant engagements: Envirotainer Holding AB ; Swedish Orphan Holding AB, ArosGruppen Holding AB (chairman)
Shares in Karo Bio: 212 500

President

Per Olof Wallström (1949), Uppsala, Sweden
Primary education or title: President Karo Bio, M.Sc. Pharm
Primary experience: Long experience from international pharmaceutical industry and biotechnology including President of Melacure Therapeutics AB and Q-Med AB and President of Northern Central and Eastern Europe and other senior positions with Bristol-Myers Squibb
Other significant engagements: Envirotainer Holding AB ; Swedish Orphan Holding AB, ArosGruppen Holding AB (chairman)
Shares in Karo Bio: 212 500

Shareholding include family and shares held through companies. Holdings as of December 31, 2007.